FDA sends stern warning to Glaxo over contamination at a penicillin plant
(By Ed Silverman for STAT) GlaxoSmithKline is recalling a “small” number of batches of its Bactroban antibiotic following a harsh rebuke
Read More
Part D/Prescription Drugs
Bristol-Myers pays $30 million to settle kickback charges
(By Ed Silverman for STAT) After nearly a decade of litigation, Bristol-Myers Squibb on Monday agreed to pay $30 million
Read MoreFDA Sanctions Off-Label Drug Promotion
(By Deborah Mazer and Gregory Curfman, for Health Affairs Blog, July 19, 2016) Physicians have the authority to prescribe drugs
Read MoreGeneric Versions of Crestor Coming Soon
U.S. District Judge Randolph Moss refused to issue a temporary restraining order blocking the approval of new generic versions of
Read MoreMedicaid’s Most Costly Outpatient Drugs
(By Katherine Young, Robin Rudowitz, Rachel Garfield, and Marybeth Musumeci for Kaiser Family Foundation) The launch of several expensive hepatitis
Read MoreTargrisso: Second-line Treatment Met Its Goal
AstraZeneca said its experimental lung cancer drug Tagrisso met its main goal as a second-line therapy in a late-stage drug
Read MoreIt All Comes Down to Money
In the multibillion-dollar legal battle between Anthem Inc. and Express Scripts it all centers on the high drug prices with
Read MoreFraud Concerns Emerge As Compounding Drug Sales Skyrocket
(By Julie Appleby for Kaiser Health News) Government spending on “compounded” drugs that are handmade by retail pharmacists has skyrocketed,
Read MoreSynthetic marijuana drives a growing number of overdoses nationwide
(By Lindzi Wessel for STAT) Just two days after a suspected synthetic marijuana poisoning in New York City sent 33
Read MoreInsurers Can Reduce Drug Prices, If Policymakers Let Them
(By David Howard for Health Affairs Blog, July 14, 2016 Whilst decrying rapid increases in drug spending and prices, elected
Read More